Annovis Announces Preclinical Data Demonstrating Synergistic Effect Of Buntanetap Combined With Trulicity In A Mouse Model Of Alzheimer's
Portfolio Pulse from Benzinga Newsdesk
Annovis announced preclinical data showing a synergistic effect of Buntanetap combined with Trulicity in a mouse model of Alzheimer's.
August 06, 2024 | 12:04 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Annovis announced preclinical data showing a synergistic effect of Buntanetap combined with Trulicity in a mouse model of Alzheimer's.
The announcement of positive preclinical data is likely to boost investor confidence in Annovis, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100